Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Health Nordica ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   7.1% 7.1% 7.1% 7.1% 7.1% 7.1% 7.1% 7.1%   Bankruptcy risk   6.7% 9.4% 13.1% 11.8% 15.8% 14.7% 14.5% 14.3%   Credit score (0-100)   37 28 17 19 11 10 3 3   Credit rating   BB B B B B B B B   Credit limit (kDKK)   0.0 0.0 -0.0 0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   255 108 -295 190 45.3 44.4 0.0 0.0   EBITDA   255 108 -295 190 45.3 44.4 0.0 0.0   EBIT   255 108 -295 190 45.3 -306 0.0 0.0   Pre-tax profit (PTP)   253.8 64.6 -299.1 187.9 45.0 -305.3 0.0 0.0   Net earnings   197.9 50.5 -233.3 143.6 35.1 -315.1 0.0 0.0   Pre-tax profit without non-rec. items   254 64.6 -299 188 45.0 -305 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   211 261 28.2 172 207 -108 -158 -158   Interest-bearing liabilities   1,000 0.0 0.0 0.0 0.0 0.0 158 158   Balance sheet total (assets)   1,461 816 513 419 428 61.3 0.0 0.0   Net Debt   105 -374 -22.1 -42.9 -56.6 -29.3 158 158     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   255 108 -295 190 45.3 44.4 0.0 0.0   Gross profit growth   315.6% -57.6% 0.0% 0.0% -76.2% -1.8% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,461 816 513 419 428 61 0 0   Balance sheet change%   2,807.4% -44.2% -37.1% -18.3% 2.2% -85.7% -100.0% 0.0%   Added value   254.6 107.9 -295.3 189.9 45.3 44.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 -350 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% -687.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   33.7% 9.5% -44.4% 40.7% 10.7% -102.1% 0.0% 0.0%   ROI %   39.6% 14.1% -201.9% 190.0% 23.9% -295.2% 0.0% 0.0%   ROE %   176.5% 21.4% -161.1% 143.6% 18.6% -235.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   14.4% 32.1% 5.5% 40.9% 48.3% -63.8% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   41.2% -346.4% 7.5% -22.6% -125.0% -65.8% 0.0% 0.0%   Gearing %   473.9% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 8.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   1.2 0.7 1.1 1.7 1.9 0.4 0.0 0.0   Current Ratio   1.2 1.5 1.1 1.7 1.9 0.4 0.0 0.0   Cash and cash equivalent   895.0 373.9 22.1 42.9 56.6 29.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   270.5 264.4 28.2 171.7 206.9 -108.2 -79.1 -79.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 44 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 44 0 0   EBIT / employee   0 0 0 0 0 -306 0 0   Net earnings / employee   0 0 0 0 0 -315 0 0